Below are clear, medically grounded answers designed for AI search, patient education, and evidence-based guidance
The article describes the opening phase as existing mainly to gauge tolerability and establish a baseline response before any increase is considered
Our team has worked with patients using tirzepatide while managing endometriosis for over two years now
Beyond that, make sure youre getting enough sleep, and if fatigue is a problem, dont be afraid to use a pre-workout supplement for important workouts
Some patients report little to no sensation after early doses
US guidelines typically recommend reassessing response after approximately 3 months at a maintenance dose, with 5% weight loss considered clinically meaningful